Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.32 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.30 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.30 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.30 |
| ▸ | F11 | P03951 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL933194 | 1.00 | USP30 (0.32) | USP30CHEK2KMT2AGPR119PIK3CD | |
| SCHEMBL933077 | 0.94 | USP30 (0.32) | USP30CHEK2KMT2AGPR119 | |
| SCHEMBL933079 | 0.94 | USP30 (0.32) | USP30CHEK2KMT2AGPR119 | |
| SCHEMBL1882908 | 0.93 | CHEK2 (0.35) | CHEK2KMT2AGPR119PIK3CDPIK3CA | |
| SCHEMBL1890113 | 0.91 | CHEK2 (0.36) | CHEK2KMT2AGPR119PIK3CDPIK3CA | |
| SCHEMBL933074 | 0.91 | USP30 (0.31) | USP30CHEK2KMT2AGPR119 | |
| SCHEMBL12661209 | 0.87 | CHEK2 (0.34) | CHEK2KMT2AGPR119PIK3CDPIK3CA | |
| SCHEMBL1044322 | 0.86 | CHEK2 (0.35) | CHEK2KMT2AGPR119F11 | |
| SCHEMBL1887080 | 0.84 | CHEK2 (0.36) | CHEK2KMT2AGPR119F11 | |
| SCHEMBL1890115 | 0.84 | CHEK2 (0.32) | CHEK2GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011004276-A1 | HEPATITIS C VIRUS INHIBITORS | PFIZER LIMITED (GB) | 2011-01-13 | — | — | WO | disclosed |